about
What Is the Best Definitive Treatment for Graves’ Disease? A Systematic Review of the Existing LiteratureExcessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal ModelsDevelopment and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' DiseaseImmunosuppressive treatment for immune thrombocytopenia which masked Graves' diseaseImmune thrombocytopenia and autoimmune thyroid disease: a controversial overlapNovel Application of Quantitative Single-Photon Emission Computed Tomography/Computed Tomography to Predict Early Response to Methimazole in Graves' Disease.Current and emerging treatment options for Graves' hyperthyroidism.Dual thyroid ectopia with graves' disease: a case report and a review of the literature.Thyroid hormone regulation of metabolismTargeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with RituximabCancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden.Fetal microchimeric cells in blood of women with an autoimmune thyroid disease.PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTENComorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD.37-year-old woman with palpitations and fatigueDecrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptorAtypical Presentation of Hashimoto's Disease in an Adolescent: Thyroid-Associated OphthalmopathyDiagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease.A second course of antithyroid drug therapy for recurrent Graves' disease: an experience in endocrine practiceDual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.Clinical and socioeconomic factors influence treatment decisions in Graves' diseaseBlocking type TSH receptor antibodies.Atypical clinical manifestations of graves' disease: an analysis in depthPrediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease.Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature.Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.Thyrotoxicosis: an under-recognised aetiology.Characterization of Regulatory B Cells in Graves' Disease and Hashimoto's ThyroiditisRadiation therapy as part of the therapeutic regimen for extensive multilocular myxedema in a patient with exophthalmos, myxedema and osteoarthropathy syndrome: A case report.Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis.Human fibrocytes coexpress thyroglobulin and thyrotropin receptorFactors predicting abnormal liver function tests induced by Graves' disease alone: a retrospective cohort study.Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.Current concepts in graves' disease.Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritisTSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.Estimated glomerular filtration rate by serum creatinine or standardized cystatin C in Japanese patients with Graves׳ disease.A patient with Graves' disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody
P2860
Q22306156-9EAD9726-4944-46A9-A248-19D6DC150EA8Q28067414-34590588-DEE9-47D4-8FA0-57E7DAAB6023Q30679626-30B22536-CF50-4CE4-910D-0BF604A6D8B8Q33422630-E278270A-0C92-4BC9-85CB-0E911D1B8EAEQ33426875-00B51E2B-C453-4FDE-AD53-731C4A1895FBQ33561428-5F88B4C1-E77E-492E-8DDD-16DB5172E1BEQ33635029-855C178C-D280-43EB-904D-97A10BD4210FQ33704662-77D7B7F3-43D1-4AE1-A7A1-FA9B403478C5Q33707954-58A6F100-C2A1-4A5D-A3C5-D76A2DA847B7Q33741009-B18237AE-92B7-43F6-A757-4DA8F6302A21Q33834350-C43AF2AD-D4A4-472D-B680-6E48D3DB8DECQ34117836-C65F56AC-D4A9-4409-9542-2328DEFBCB2FQ34131044-1E50A25B-0D27-4BCA-B5E0-703D6C4F8DD4Q34327276-8901908E-3082-4BD7-9411-0BB1A9A946D6Q34450970-EC5EE64B-9F21-44FC-84D5-B824011FF6CDQ34493895-B44377AA-D7A5-40BC-B993-2A64A503CEB6Q34622464-1040D8B4-2B94-4AF8-9445-956EA194EB23Q34949203-9509E46E-6ED7-4CE2-A1F2-14717CBA3F95Q35033575-657B3B93-96DE-4537-B8D0-6CADAD6AB966Q35062399-E909B02F-4330-488E-8425-237F54A6C52FQ35131251-D35D5877-FA22-438F-8010-38D3F4D9CE76Q35137551-181DE5A5-2A22-4E2E-9FD6-63973DFAE18CQ35309934-D555BA47-9B4E-4E18-9462-311FD8CB488EQ35503986-CB9DD67A-E80C-46EB-860D-95F31DC2E5A9Q35559999-F1B011E1-AF77-4D66-9ED7-E159D19ED17EQ35594705-B792B8A1-384E-43D2-B593-27A952E9BE86Q35597978-0414E45C-CCB6-41CE-9E8C-3DE5B23552F4Q35617803-20DC1F06-20EA-402F-81DA-4CC2882F64B0Q35640363-CBF9DA18-AEB3-4AB4-927F-EAD700B4661FQ35643325-75006840-EA25-4C25-AE8E-0D7C6AA74663Q35742184-5E3FE1E3-C8C3-4937-9B5A-F29FD3C39E14Q35808258-31F7DFEB-38A1-4B28-A30B-8EF3F3124D00Q35983102-325219BA-2512-4FB2-8DE9-E537889DEAB1Q36151544-DEDB00CB-EAFF-4B7C-96E3-39806842A404Q36164346-7575EF2A-BA09-44BA-9A3E-3B93D7DEF16FQ36328020-D7236202-4E63-418E-BDEB-8C02FFB205FBQ36350093-BE0FF8AD-534F-43C0-B813-0F0BC6CF5E52Q36393011-4195A43E-F14B-4767-8375-5A5C1E29F65FQ36398623-172C423C-C1A8-43B8-8B09-0663224544E2Q36478568-1E529537-EB9B-4CB0-AD9C-854D023C5172
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical practice. Graves' disease.
@ast
Clinical practice. Graves' disease.
@en
Clinical practice. Graves' disease.
@nl
type
label
Clinical practice. Graves' disease.
@ast
Clinical practice. Graves' disease.
@en
Clinical practice. Graves' disease.
@nl
prefLabel
Clinical practice. Graves' disease.
@ast
Clinical practice. Graves' disease.
@en
Clinical practice. Graves' disease.
@nl
P356
P1476
Clinical practice. Graves' disease.
@en
P2093
Gregory A Brent
P304
P356
10.1056/NEJMCP0801880
P407
P577
2008-06-01T00:00:00Z